Carlos E. Rivera O. retweetledi
CHOICE-2: Adjunctive Intra-Arterial Alteplase After Successful Thrombectomy for Acute Ischemic Stroke. @JAMA_current jamanetwork.com/journals/jama/…
English
Carlos E. Rivera O.
222 posts
Carlos E. Rivera O.
@ceriverao
Neurólogo Intervencionista Clínica Universitaria Colombia Fundación Hospital San Carlos Hospital San Rafael -Clinica Centenario
Katılım Ağustos 2008
213 Takip Edilen132 Takipçiler
Carlos E. Rivera O. retweetledi
🚨 The ATTRACTION trial at #ESOC2026 shows adjunct tirofiban after successful thrombectomy improves outcomes in acute ischaemic stroke.
✅ 49.3% vs 43.3% functional independence (90 days)
📈 Significant benefit (RR 1.15; p=0.01)
🧠 No increase in sICH or mortality
@ESOstroke
English
Carlos E. Rivera O. retweetledi
#ESOC2026 Day2
1. ATLAS: EVT improves function & reduces mortality in large-core stroke ✅
2. CASES: Simultaneous CAS safe + higher recanalization; non-inferiority unproven
3. LATE-MT: 24–72h EVT improves function but ↑ bleeding/mortality
English
Carlos E. Rivera O. retweetledi
#MondayTip
#ISC2026
🌎ISC delivered fewer “home runs” and more hard truths: what works, what doesn’t, and where selection matters most in stroke care
From extended-window thrombolysis to FXIa inhibition, #ISC26 highlights where stroke care is truly moving — and where it isn’t.
English
Carlos E. Rivera O. retweetledi
Just Accepted!
🏥🌎Analysis of 218,000+ ischemic stroke patients across 1,130 hospitals
🧠Door-to-imaging time ranged from 7-41 mins
💉IVT rates ranged from <1% to 52%
journals.sagepub.com/doi/abs/10.117… @NurseResearch @AdamKobayashiMD @mindbodyinsight @CarlosAbantoA @rupss7
English
Carlos E. Rivera O. retweetledi
Have you ever struggled with finding the true lumen of the dissected carotid or vertebral artery? 🧐
💡Check our bail out technique that is easy to use and may save your day / patients’ brain 🧠 rdcu.be/eAj02
English
Carlos E. Rivera O. retweetledi
Carlos E. Rivera O. retweetledi
Interesting findings of the COBRA trial showing lower bleeding risk with apixaban compared to Rivaroxaban in VTE. This may partially explain some of the discrepancy in findings between the SECRET trial (using Rivaroxaban) & ACTION-CVT in patients with CVT (2/3rd used apixaban).
Alex Spyropoulos@AlexSpyropoul
Cobra Trial: #apixaban safer than #rivaroxaban for venous #thrombosis treatment #ISTH2025 @AnticoagForum @Vasculearn @PERTConsortium @thrombosisday @ThrombosisCan @canvector @EuropeanTHA @CMichaelGibson
English
Carlos E. Rivera O. retweetledi
These guidelines are the result of an impressive collaborative effort involving module working group chairs, members and methodologists.
As Co-chair of the ESO Guideline Board, it has been a privilege to support this process and witness the dedication of everyone involved.
⬇️
European Stroke Org@ESOstroke
#ESOC2025 | The ESO Guideline Board is delighted to present 4 new evidence-based guidelines that address 🔹 Management of Intracerebral Haemorrhage (ICH) 🔹 Aphasia Rehabilitation 🔹 Visual impairment screening 🔹 Motor Rehabilitation 📖 ow.ly/cOE350VWsbE #VoiceOfStroke
English
Carlos E. Rivera O. retweetledi
Here's a review on some of the inherited thrombophilias that are frequently ordered as part of the hypercoagulability workup in arterial ischemic stroke. Read on to see which are recommended to be sent in the acute stroke workup, and which should not be ordered. #stroke #MedEd #neurotwitter #medtwitter #medstudenttwitter #neurology
GIF
English
Carlos E. Rivera O. retweetledi
Great summary !
World Stroke Academy@WorldStrokeEd
#MondayTip Key studies on #DOAC vs VKA in CVT 🧠Several observational studies and small but important RCTs have evaluated the efficacy and safety of DOACs as an alternative to VKAs in Cerebral Venous Thrombosis ✅Results support DOACs as a reasonable treatment option
English
Carlos E. Rivera O. retweetledi
The TEMPO-2 trial led to controversy regarding the utility of thrombolysis in patients with NIHSS 0-5 who have an intracranial vessel occlusion. Below is a thread dissecting the trial and available data on minor stroke as well as my interpretation of the trial and practice. 🧵
English
Carlos E. Rivera O. retweetledi
Microvascular Perfusion Abnormalities After Successful Endovascular Treatment in Acute Ischemic Stroke — An Indicator of Functional Outcomes
In this #BloggingStroke post, @chris7ianb discusses #Stroke article by @adnan_mujanovic et al. #AHAJournals
ahajournals.org/do/10.1161/blo…
English
Carlos E. Rivera O. retweetledi
CAD Infographic
ahajournals.org/doi/full/10.11…)%20can%20cause%20permanent%20injury.
#SVIN24 @SVINJournal @svinsociety @AlexandraCzap @SposatoL @JayDoliaMD @JayKinariwala @DineshJillella @SitaraKoneru @SuspectedLVO @Nirav_r_bhatt @DiogoHaussen @SharashidzeVera @fati_k_MD
English
Carlos E. Rivera O. retweetledi
Early reports suggest Middle Meningeal Artery Embolization #MMAe for medically refractory #headaches and #migraines has beneficial effects for symptomatic control.💥
Lidocaine injection into STA to meningeal artery anastomotic branches provides on the table confirmation of improvement followed by Onyx Embolization for lasting relief.
#endovascular #MMAe #neurosurgery #headache
English
Carlos E. Rivera O. retweetledi
What's the optimal blood pressure for acute stroke management after EVT? Thanks @AshuPJadhav! 👏🏼
jamanetwork.com/journals/jaman…
#NeuroTwitter
English
Carlos E. Rivera O. retweetledi
#ESOC2024
📢NEWS Basilar ESO guideline
👉IVT up to 24 hs
👉EVT up to 24 hs for NIHSS ≥10
👉EVT/IVT if NOT extensive y/or brainstem isquemia
👉Aspiration better than stent retriever
👉Rescue PTA/stenting if failed EVT
👉Add APT if complicated EVT an not IVT
English
Carlos E. Rivera O. retweetledi
Acute Ischemic Stroke With Tandem Occlusion Requiring Cervical and Intracranial Revascularization on @EVToday evtoday.com/articles/2024-…
English
Carlos E. Rivera O. retweetledi
Large Core Trials Summary. Thanks, neurosister @SitaraKoneru !
@caseyalbin @EmoryNeuroCrit #neurotwitter #MedEd
ahajournals.org/doi/full/10.11…
English
What is the most likely diagnosis in this 30 y/o M w/ HA & subacute deterioration in mental status?
🔷Audiology assessment showed bilateral sensorineural hearing loss
🔷B/l retinal whitening on dilated eye exam
More images in 🧵
#Neurology #radres #MedEd @AlbanyMedRadRes
English